Begin main content

Intravenous Ketamine for the Treatment of Pain Syndromes: Clinical Effectiveness

Last updated: June 7, 2013
Project Number: RB0591-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of intravenous (IV) ketamine for the treatment of recalcitrant Chronic Regional Pain Syndrome?
  2. What is the clinical effectiveness of IV ketamine for the treatment of Fibromyalgia?
  3. What is the clinical effectiveness of IV ketamine for the treatment of Reflex Sympathetic Dystrophy?

Key Message

One systematic review, two randomized controlled trials, and four non-randomized studies were identified regarding the clinical effectiveness of intravenous (IV) ketamine for the treatment of chronic regional pain syndrome. No health technology assessments, systematic reviews, randomized controlled trials, or non-randomized studies were identified regarding the clinical effectiveness of IV ketamine for the treatment of fibromyalgia or reflex sympathetic dystrophy.